Holen Sie sich die Stockscreener-App
143.51
0.82%
1.25
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt ZTS?
Forum
Prognose
Dividendenhistorie
Schlusskurs vom Vortag:
$142.26
Offen:
$141.55
24-Stunden-Volumen:
2.21M
Relative Volume:
0.74
Marktkapitalisierung:
$63.59B
Einnahmen:
$9.39B
Nettoeinkommen (Verlust:
$2.62B
KGV:
24.69
EPS:
5.8121
Netto-Cashflow:
$2.22B
1W Leistung:
+0.46%
1M Leistung:
-3.22%
6M Leistung:
-4.90%
1J Leistung:
-25.55%
1-Tages-Spanne:
$141.11
$143.54
1-Wochen-Bereich:
$140.65
$145.22
52-Wochen-Spanne:
$139.34
$196.55
Zoetis Inc Stock (ZTS) Company Profile
Firmenname
Zoetis Inc
Sektor
Telefon
973-822-7000
Adresse
10 SYLVAN WAY, PARSIPPANY, NJ
Vergleichen Sie ZTS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ZTS
Zoetis Inc
|
143.48 | 63.05B | 9.39B | 2.62B | 2.22B | 5.8121 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.79 | 43.33B | 29.96B | 957.25M | 4.77B | 0.2956 |
|
HLN
Haleon Plc Adr
|
9.18 | 40.43B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
20.14 | 22.97B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
433.24 | 19.90B | 3.08B | 1.24B | 1.07B | 25.61 |
Zoetis Inc Stock (ZTS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-17 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2025-06-18 | Herabstufung | Stifel | Buy → Hold |
| 2024-12-02 | Eingeleitet | Leerink Partners | Outperform |
| 2024-07-25 | Eingeleitet | BTIG Research | Buy |
| 2024-01-12 | Bestätigt | Stifel | Buy |
| 2023-12-19 | Fortgesetzt | Jefferies | Buy |
| 2023-12-07 | Eingeleitet | Exane BNP Paribas | Outperform |
| 2023-09-06 | Eingeleitet | HSBC Securities | Buy |
| 2022-07-12 | Eingeleitet | Piper Sandler | Overweight |
| 2021-11-18 | Eingeleitet | Morgan Stanley | Overweight |
| 2021-08-05 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-07-16 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2021-03-08 | Hochstufung | BofA Securities | Neutral → Buy |
| 2021-03-08 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2020-09-21 | Eingeleitet | Atlantic Equities | Overweight |
| 2020-08-14 | Hochstufung | Edward Jones | Hold → Buy |
| 2020-08-12 | Herabstufung | Gabelli & Co | Buy → Hold |
| 2020-05-27 | Eingeleitet | Jefferies | Buy |
| 2020-01-10 | Eingeleitet | Raymond James | Mkt Perform |
| 2019-09-09 | Eingeleitet | Goldman | Buy |
| 2019-07-01 | Herabstufung | BofA/Merrill | Buy → Neutral |
| 2019-06-11 | Eingeleitet | Barclays | Overweight |
| 2019-05-23 | Eingeleitet | Guggenheim | Buy |
| 2019-05-03 | Herabstufung | Gabelli & Co | Buy → Hold |
| 2019-03-20 | Eingeleitet | SunTrust | Hold |
| 2019-03-04 | Hochstufung | Stifel | Hold → Buy |
| 2019-01-23 | Eingeleitet | UBS | Neutral |
| 2018-10-15 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2018-08-22 | Herabstufung | Stifel | Buy → Hold |
| 2018-08-03 | Bestätigt | Stifel | Buy |
| 2018-04-19 | Bestätigt | Citigroup | Buy |
| 2018-03-19 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2018-02-16 | Bestätigt | Stifel | Buy |
| 2018-01-04 | Hochstufung | Citigroup | Neutral → Buy |
Alle ansehen
Zoetis Inc Aktie (ZTS) Neueste Nachrichten
Leerink Partnrs Issues Negative Estimate for Zoetis Earnings - MarketBeat
Equitable Trust Co. Sells 1,975 Shares of Zoetis Inc. $ZTS - MarketBeat
52,798 Shares in Zoetis Inc. $ZTS Acquired by Wilson Asset Management International PTY Ltd. - MarketBeat
Morningstar Investment Management LLC Makes New Investment in Zoetis Inc. $ZTS - MarketBeat
Zoetis Inc. $ZTS Stake Lessened by Alpine Woods Capital Investors LLC - MarketBeat
Envestnet Portfolio Solutions Inc. Has $10.52 Million Holdings in Zoetis Inc. $ZTS - MarketBeat
Concurrent Investment Advisors LLC Boosts Stock Position in Zoetis Inc. $ZTS - MarketBeat
Zoetis Gains CVMP Backing for Lenivia, Eyes EU Approval in Dog OA Pain - sharewise.com
Zoetis Could Face Pressure if Recessionary Conditions Cause Pullback in Pet Health Spending - Morningstar
Leerink Partners Adjusts Zoetis' Price Target to $152 From $153, Keeps Market Perform Rating - MarketScreener
News impact scoring models applied to Zoetis Inc.Trade Risk Report & Safe Entry Trade Signal Reports - newser.com
Montrusco Bolton Investments Inc. Sells 102,497 Shares of Zoetis Inc. $ZTS - MarketBeat
Zoetis Inc. (ZTS) Stock Analysis: Exploring a Potential 34% Upside in the Animal Health Sector - DirectorsTalk Interviews
Apollon Wealth Management LLC Acquires 6,057 Shares of Zoetis Inc. $ZTS - MarketBeat
Index Fund Advisors Inc. Invests $621,000 in Zoetis Inc. $ZTS - MarketBeat
Vanguard Personalized Indexing Management LLC Grows Holdings in Zoetis Inc. $ZTS - MarketBeat
Sector ETF performance correlation with Zoetis Inc.July 2025 Recap & Fast Entry Momentum Alerts - newser.com
What valuation ratios show for Zoetis Inc. (ZOE) stockQuarterly Profit Summary & Consistent Growth Stock Picks - newser.com
What analysts say about Zoetis Inc stockStock Buyback Announcements & High Profit Trading Signals - earlytimes.in
Fulcrum Capital LLC Buys 3,847 Shares of Zoetis Inc. $ZTS - MarketBeat
OFI Invest Asset Management Purchases 67,984 Shares of Zoetis Inc. $ZTS - MarketBeat
Stonehage Fleming Financial Services Holdings Ltd Has $98.04 Million Stock Holdings in Zoetis Inc. $ZTS - MarketBeat
Callan Family Office LLC Has $2.45 Million Stake in Zoetis Inc. $ZTS - MarketBeat
Zoetis Inc. $ZTS Shares Sold by US Bancorp DE - MarketBeat
Zoetis Inc. (NYSE:ZTS) Announces Quarterly Dividend of $0.50 - MarketBeat
Galvin Gaustad & Stein LLC Raises Stock Holdings in Zoetis Inc. $ZTS - MarketBeat
Eastern Bank Has $3.77 Million Stock Position in Zoetis Inc. $ZTS - MarketBeat
Davis Rea LTD. Purchases 20,268 Shares of Zoetis Inc. $ZTS - MarketBeat
Blue Zone Wealth Advisors LLC Raises Holdings in Zoetis Inc. $ZTS - MarketBeat
Zoetis’ dog osteoarthritis pain treatment receives positive EU opinion By Investing.com - Investing.com Nigeria
Zoetis (ZTS): EMA Supports New Canine Osteoarthritis Treatment - GuruFocus
Zoetis gains EMA panel endorsement for Lenivia for osteoarthritis pain in dogs - Seeking Alpha
Zoetis, Inc. Experiences Revision in Its Stock Evaluation Amid Market Dynamics - Markets Mojo
Zoetis (ZTS) Awaits EU Approval for Lenivia, an Osteoarthritis T - GuruFocus
Zoetis’ dog osteoarthritis pain treatment receives positive EU opinion - Investing.com
(izenivetmab) to Reduce Pain Associated with Osteoarthritis (OA) in Dogs - Business Wire
Zoetis (ZTS): Assessing Valuation Following Dividend Announcement and FDA Nod for Dectomax-CA1 Injectable - Yahoo Finance
Regression analysis insights on Zoetis Inc. performanceJuly 2025 Opening Moves & AI Based Buy/Sell Signal Reports - newser.com
Using Python tools to backtest Zoetis Inc. strategies2025 Dividend Review & Technical Entry and Exit Alerts - newser.com
Market reaction to Zoetis Inc.’s recent newsJuly 2025 Pullbacks & Safe Capital Growth Stock Tips - newser.com
Blair William & Co. IL Sells 260,409 Shares of Zoetis Inc. $ZTS - MarketBeat
Live market analysis of Zoetis Inc.2025 Valuation Update & Fast Exit Strategy with Risk Control - newser.com
Is Zoetis Inc. Class stock undervalued at current price2025 Top Decliners & AI Optimized Trading Strategy Guides - newser.com
Zoetis Inc. $ZTS Stock Position Decreased by NBT Bank N A NY - MarketBeat
Is Zoetis Inc. (ZOE) stock a buy during volatile marketsPortfolio Performance Report & Consistent Return Investment Signals - newser.com
How Zoetis Inc. (ZOE) stock trades under stagflationQuarterly Market Summary & Real-Time Volume Analysis Alerts - newser.com
Zoetis Inc. (ZTS) Announces Fourth Quarter Dividend - GuruFocus
Zoetis (NYSE:ZTS) Signals Robust Health with Q4 2025 Dividend Declaration, Bolstering Investor Confidence in Animal Health Sector - FinancialContent
Gothenburg FFA Chapter Receives Donation From Zoetis - Gothenburg Leader
Zoetis (NYSE:ZTS) Declares $0.50 Q4 2025 Dividend, Signaling Robust Animal Health Market - FinancialContent
Zoetis (ZTS) Maintains Quarterly Dividend, Sets Payment Date - GuruFocus
Finanzdaten der Zoetis Inc-Aktie (ZTS)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.55%
1.63%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):